| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy
|
Sun, Huiying
|
|
2016
|
7 |
3 |
p. 196-210
|
artikel
|
| 2 |
CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy
|
Sun, Huiying
|
|
|
7 |
3 |
p. 196-210
|
artikel
|
| 3 |
pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer
|
Yarchoan, Mark
|
|
2016
|
7 |
3 |
p. 188-195
|
artikel
|
| 4 |
pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer
|
Yarchoan, Mark
|
|
|
7 |
3 |
p. 188-195
|
artikel
|
| 5 |
Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study
|
Clendenen, Tess V.
|
|
2016
|
7 |
3 |
p. 178-187
|
artikel
|
| 6 |
Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study
|
Clendenen, Tess V.
|
|
|
7 |
3 |
p. 178-187
|
artikel
|
| 7 |
Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide
|
Kroiss, Matthias
|
|
2016
|
7 |
3 |
p. 211-218
|
artikel
|
| 8 |
Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide
|
Kroiss, Matthias
|
|
|
7 |
3 |
p. 211-218
|
artikel
|
| 9 |
TERT Promoter Mutations in Thyroid Cancer
|
Alzahrani, Ali S.
|
|
2016
|
7 |
3 |
p. 165-177
|
artikel
|
| 10 |
TERT Promoter Mutations in Thyroid Cancer
|
Alzahrani, Ali S.
|
|
|
7 |
3 |
p. 165-177
|
artikel
|
| 11 |
The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer
|
Capper, Cameron P.
|
|
2016
|
7 |
3 |
p. 149-164
|
artikel
|
| 12 |
The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer
|
Capper, Cameron P.
|
|
|
7 |
3 |
p. 149-164
|
artikel
|
Tijdschrift beschrijving